Skip to main content
. Author manuscript; available in PMC: 2018 Oct 5.
Published in final edited form as: J Allergy Clin Immunol. 2018 Mar 2;142(4):1285–1296. doi: 10.1016/j.jaci.2018.01.039

Figure 5. Decreased class-switched memory B cells and increased CD21low B cells in NFKB1 LOF variant carriers.

Figure 5

(A) Absolute numbers of CD19+ B cells; each dot represents a single individual and their age. In grey are age-dependent reference values. (B-E) Percentages within CD19+CD20+ B lymphocytes of (B) CD27+IgD+ (non-switched memory or marginal-zone B cells) and CD27+IgD- (switched memory B cells), or (C) CD27+IgG+, or (D) CD27+IgA+, or (E) CD21lowCD38low/dim. (HD healthy donor; CU clinically unaffected or CA clinically affected individuals with LOF variant in NFKB1.) Gating strategy is shown in Figure E6A. Only individuals with sufficient B cells could be analyzed. P-values were determined by one-way (Figure 5E) or two-way (Figure 5B) ANOVA with Bonferroni post-hoc test or unpaired Student’s t-test (Figure 5C,D), ns not significant, **P≤0.01, ***P≤0.001.